GPs' management strategies for patients with insomnia: a survey and qualitative interview study

Br J Gen Pract. 2014 Feb;64(619):e112-9. doi: 10.3399/bjgp14X677176.

Abstract

Background: Patients frequently experience sleep problems and present to primary care. However, information is limited regarding the management strategies that GPs employ.

Aim: To gain an understanding of current GP management strategies for insomnia.

Design and setting: A postal questionnaire survey and qualitative interviews with GPs in the south of England.

Method: A postal survey of 296 GPs and qualitative interviews were carried out with 23 of the GPs.

Results: The survey response rate was 56% (166/296). GPs look for signs of depression and anxiety in patients and if present treat these first. 'Sleep hygiene' advice is provided by 88% (147/166) of GPs but often seems insufficient and they feel under pressure to prescribe. Benzodiazepines and Z drugs are prescribed, often reluctantly, for short periods, because of known problems with dependence and tolerance. Many GPs prescribe low-dose amitriptyline for insomnia although it is not licensed for this indication. For insomnia 95% (157/166) of survey responders 'ever prescribe' amitriptyline, with 31% (52/166) stating they do so commonly. Most GPs perceived amitriptyline to be effective and a longer-term option for those with ongoing sleep problems. GPs report a lack of knowledge and confidence in the provision and use of psychological therapies, such as cognitive behavioural therapy (CBT), in the management of insomnia.

Conclusion: GPs often find 'sleep hygiene' advice is insufficient for managing insomnia and report frequently prescribing medication, including amitriptyline (off licence), which is often based on perceived patient pressure for a prescription. Patients are rarely offered psychological therapies such as CBT for insomnia, despite evidence suggesting its potential effectiveness.

Keywords: amitriptyline; general practice; insomnia; management strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amitriptyline / therapeutic use
  • Antidepressive Agents, Tricyclic / therapeutic use*
  • Anxiety / diagnosis
  • Anxiety / drug therapy*
  • Anxiety / epidemiology
  • Attitude of Health Personnel
  • Benzodiazepines / therapeutic use
  • Cognitive Behavioral Therapy
  • Depression / diagnosis
  • Depression / drug therapy*
  • Depression / epidemiology
  • England / epidemiology
  • Health Care Surveys
  • Health Expenditures
  • Humans
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Primary Health Care*
  • Qualitative Research
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Sleep Initiation and Maintenance Disorders / epidemiology
  • Sleep Initiation and Maintenance Disorders / etiology
  • Surveys and Questionnaires

Substances

  • Antidepressive Agents, Tricyclic
  • Benzodiazepines
  • Amitriptyline